FDA Orders Warning Labels for Fosamax, Actonel, Boniva
November 1, 2010 – Last month, the U.S. Food & Drug Administration (FDA) ordered the makers of Fosamax, Actonel, and Boniva to put warning labels on their drugs because they can lead to rare bone fractures of the thigh.
Sadly, these osteoporosis medications have also been found to lead to degeneration of the jaw bone. Avandia – a drug meant to prevent a heart attack in diabetics – actually appears to increase that risk. The FDA is now restricting Avandia’s use.
According to medical experts, the fundamental issue that needs addressing is the way prescription drugs are traditionally used. Most drugs are typically approved for short term use. But with an aging population, patients are taking some drugs for decades for chronic diseases with unanticipated side effects. A national electronic drug database is being proposed that would root out troubles with prescription drugs faster than the present method: relying on prescribing doctors to report adverse reactions to the FDA.